Compare head to head
The comparison grid we would build for a client. Best score in each row is underlined — but read the category first, because comparing a companion vendor to a full-service clinic will mislead you.
Select up to 3 vendors
1 selected
| Vendor | 8.7 Virta Health Metabolic specialist |
|---|---|
| Category | Metabolic specialist |
| Scores | |
| Clinical rigor | 9.0 |
| Outcomes evidence | 9.3 |
| Cost control | 9.1 |
| Data & reporting | 8.4 |
| Integration | 8.0 |
| Member experience | 7.6 |
| Commercial | |
| PMPM range | $40–$95 |
| Pricing model | Outcomes-based — substantial share of fees contingent on clinical results |
| Performance guarantees | Up to 100% of fees at risk against A1c, weight, and medication-reduction targets |
| Minimum lives | 2,000 |
| Term | 36 months |
| Termination notice | 120 days |
| Clinical | |
| Prescribes | Yes |
| Step therapy | Yes |
| Prior authorization | No |
| BMI threshold | BMI ≥ 30, or type 2 diabetes / prediabetes at any BMI |
| Off-ramp protocol | Deprescribing is the stated clinical goal, with continuous medication-reduction tracking |
| Evidence | |
| Evidence level | Peer-reviewed observational |
| Follow-up | 1 year in the principal study, with 2- and 5-year follow-up published |
| Assessment | |
| Best for | Self-insured employers with a diabetic or prediabetic population and a mandate to bend pharmacy trend downward. |
| Watch out | Enrollment is the whole risk. Model your results at realistic uptake, not at the enrolled-member outcomes in the sales deck. |
| Verdict | The highest-conviction pick when your population fits. Nothing else here combines randomized evidence with fees genuinely at risk — but underwrite it on realistic enrollment, not on completer outcomes. |